Bispecific antibodies for delivery into the brain.

[1]  W. Pardridge,et al.  Drug Transport across the Blood–Brain Barrier , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  L. Wood,et al.  A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys , 2012, PloS one.

[3]  D. Kamei,et al.  The intracellular trafficking pathway of transferrin. , 2012, Biochimica et biophysica acta.

[4]  R. Kontermann.  Dual targeting strategies with bispecific antibodies , 2012, mAbs.

[5]  Qing-hui Zhou,et al.  Chronic Dosing of Mice with a Transferrin Receptor Monoclonal Antibody-Glial-Derived Neurotrophic Factor Fusion Protein , 2011, Drug Metabolism and Disposition.

[6]  F. Calon,et al.  In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor , 2011, Molecular Pharmacology.

[7]  W. Luk,et al.  Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target , 2011, Science Translational Medicine.

[8]  K. Scearce-Levie,et al.  A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo , 2011, Science Translational Medicine.

[9]  S. Liddelow.  Fluids and barriers of the CNS: a historical viewpoint , 2011, Fluids and Barriers of the CNS.

[10]  B. Barres,et al.  The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells , 2010, PloS one.

[11]  R. Watts,et al.  Connecting vascular and nervous system development: angiogenesis and the blood-brain barrier. , 2010, Annual review of neuroscience.

[12]  Andrew C. Chan,et al.  Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.

[13]  L. B. Thomsen,et al.  Macromolecular drug transport into the brain using targeted therapy , 2010, Journal of neurochemistry.

[14]  E. Shusta,et al.  Identification and expression profiling of blood–brain barrier membrane proteins , 2010, Journal of neurochemistry.

[15]  R. Gabathuler,et al.  Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.

[16]  W. Pardridge,et al.  Pharmacokinetics and Safety in Rhesus Monkeys of a Monoclonal Antibody-GDNF Fusion Protein for Targeted Blood-Brain Barrier Delivery , 2009, Pharmaceutical Research.

[17]  Mayur M. Patel,et al.  Getting into the Brain , 2009, CNS Drugs.

[18]  U. Müller-Ladner,et al.  Drug delivery systems for the treatment of rheumatoid arthritis , 2008 .

[19]  H. Sprong,et al.  The blood–brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells , 2005, Journal of neurochemistry.

[20]  Christilyn P. Graff,et al.  Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention. , 2003, Cancer research.

[21]  E. Morgan,et al.  Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat , 2001, Journal of neurochemistry.

[22]  R K Jain,et al.  Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[23]  C. Lok,et al.  The transferrin receptor: role in health and disease. , 1999, The international journal of biochemistry & cell biology.

[24]  W. Banks,et al.  Transport of Insulin Across the Blood-Brain Barrier: Saturability at Euglycemic Doses of Insulin , 1997, Peptides.

[25]  L. Presta,et al.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization. , 1996, Protein engineering.

[26]  R. Fine,et al.  Receptor-mediated endocytosis of transferrin at the blood-brain barrier. , 1993, Journal of cell science.

[27]  W. Pardridge,et al.  Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. , 1991, The Journal of pharmacology and experimental therapeutics.

[28]  R. Starzyk,et al.  Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Davson,et al.  A saturable mechanism for transport of immunoglobulin G across the blood-brain barrier of the guinea pig , 1990, Experimental Neurology.

[30]  W. Jefferies,et al.  Analysis of lymphopoietic stem cells with a monoclonal antibody to the rat transferrin receptor. , 1985, Immunology.

[31]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[32]  B. Iacopetta,et al.  Transferrin receptors and iron uptake during erythroid cell development. , 1982, Biochimica et biophysica acta.

[33]  K. Felgenhauer.  Protein size and cerebrospinal fluid composition , 1974, Klinische Wochenschrift.

[34]  G. Riethmüller.  Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on. , 2012, Cancer Immunity.

[35]  A. Boer,et al.  Strategies to Improve Drug Delivery Across the Blood-Brain Barrier , 2007, Clinical pharmacokinetics.

[36]  J. Connor,et al.  Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier , 1987, Journal of neuroscience research.